Jeff Sessions' Retirement Affect On Marijuana

New Post Public Reply Private Reply Replies (0) Message Board
StanleyK
1,443
Jeff Sessions' Retirement Affect On Marijuana Industry

10 Cannabis Executives Predict How AG Jeff Sessions' Retirement Will Affect the Marijuana Industry

When Attorney General Jeff Sessions tendered his resignation on November 7th, the cannabis industry took notice. As one of the most vocal marijuana opponents in the highest level of U.S. government, his resignation could pave the way for federal legalization.

With Matthew Whitaker set to take Sessions’ place, the industry could be poised for significant change in the near future. How do cannabis industry insiders feel about this news? Will it be as groundbreaking as many hope? Here are insights and predictions from 10 cannabis and hemp industry executives to provide some perspective.

Derek Peterson, CEO of Terra Tech

“Attorney General Jeff Sessions has been an impediment to the growth of the regulated cannabis industry. We believe we are at a tipping point nationally in terms of voter sentiment as well as support from lawmakers on both sides of the aisle. With Pete Sessions being voted out [of Congress] and Jeff Sessions resigning, the corridor is now open to accelerate a states’ rights approach to regulating the cannabis industry.”

Isaac Dietrich, CEO of MassRoots

“We believe it’s increasingly likely Congress could take action to regulate and tax cannabis at the federal level. We expect the perceived risks related to the cannabis industry to continue to dissipate, which could lead to a shift of institutional capital and interest from Canadian licensed producers to companies focused on the regulated United States market.”

Charlie Finnie, Chief Strategy Officer of MariMed Inc.

“Although we wish Mr. Sessions well, he was woefully out of step with the American people with regard to the myriad health and wellness benefits of cannabis. When the Republican ex-speaker of the House John Boehner writes an Op-Ed piece entitled 'Cannabis Should be Legalized,' that tells you all you need to know.”

Khurram Malik, CEO of Biome

“AG Sessions’ anti-cannabis rhetoric was a lot stronger than any other part of the federal government, including Congress and the White House, and quite a few things he announced were inconsistent with other parts of the government. Ultimately, most of his anti-cannabis rhetoric and attempted policies did not have a granular impact.

“The hope is that there will be a lot less confusion and distracting noise coming out of the AG’s office on a go forward basis. We also still expect the White House to move forward with legalizing medical cannabis at the federal level before the 2020 elections, and having an AG that is on board with that would be helpful for all.”

Dr. Stuart Titus, CEO of Medical Marijuana Inc.

“The unexpected resignation of U.S. Attorney General Jeff Sessions represents another positive event for the cannabis industry. Sessions' stance on cannabis had been a major impediment toward cannabis reform, and now industry participants hold new hopes for sweeping change at the Federal level. Along with the defeat of Pete Sessions in the U.S. House of Representatives, there is renewed enthusiasm for cannabis-friendly legislation to be passed in the coming year.”

Jeffrey M. Zucker, President of Green Lion Partners

“Jeff Sessions and his ignorance leaving office is a definite win for cannabis patients, the movement and the fight to end the drug war and its racially disparate enforcement as a whole. We’ll have to wait and see how Matthew Whitaker approaches cannabis, but it can’t get much worse than Sessions, and hopefully, this is the start of some federal progress and protection for those participating in cannabis in the many states that have enacted laws. President Trump has seemed amenable to making cannabis a states’ rights issue, and it wouldn’t surprise me if we see changes to that effect on the federal level in the near future.”

George Archos, CEO of Verano Holdings

“The election results send a clear message that more Americans want access to medical or adult-use cannabis because they have taken the time to get educated about cannabis’ proven health benefits. Former AG Sessions and other government officials lose credibility by maintaining that cannabis has no medicinal value when our own FDA has approved a cannabis-derived drug for treating epilepsy.”

“President Trump has repeatedly stated he will protect states’ rights relative to cannabis, and more recently, he stated he is exploring ending the prohibition on cannabis. We are optimistic that a new Attorney General will take President Trump’s cue and quickly reinstate the Cole memo to end ambiguity regarding states’ rights in this matter.”

“Additionally, we hope the new Attorney General will determine that it is not wise to spend tax dollars on incarcerating thousands of people for marijuana convictions when cannabis has been proven to be safer than the alcohol found in almost every American household.”

Wil Ralston, President of SinglePoint

“Jeff Sessions' resignation could be a huge event for the cannabis industry since he has openly been against the industry and used his powers to slow its growth. One of the biggest potentials here is opening up access to banking.”

Frank Lane, President of CFN Media

“The resignation of Jeff Sessions marks another key turning point for the cannabis industry, removing a key obstructionist to cannabis reform from the Justice Department. Many cannabis stocks have already surged following the news in hopes that the resignation will usher in a change to federal cannabis policy, including passage of the STATES Act. We are cautiously optimistic.”

Bruce Perlowin, CEO of Hemp, Inc.

“Sessions has long been a hindrance to the growth of the marijuana and hemp infrastructure in the U.S. and it's a huge win for the industry to see him resign. We are currently in the process of creating jobs for rural farmers throughout the U.S. by creating a chain of local processing centers so farmers can switch to hemp and make a profit, and this latest policy development should lead to real change that can create jobs and spur an agricultural revolution throughout the U.S.”

One thing is clear based on these ten cannabis executives’ perspectives. The resignation of Attorney General Jeff Sessions is expected to be a positive change for the marijuana industry. With more Americans as well as an increasing number of Republicans and Democrats at all levels of government supporting legalization, cannabis-industry insiders see Sessions’ resignation as a key step forward.

Source...

Susan Gunelius
VIP Contributor
Marketing, Branding, Copywriting, Email and Social Media Expert

November 13, 2018
Opinions expressed by Entrepreneur contributors are their own.

Hemp, Inc. (HEMP) Stock Research Links

HEMP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 18

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 46

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 30

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Gene-Editing Therapy CS-121 Revolutionizes Hyperlipidemia Treatment

Updated Category News Views 232

Transformative Progress in Gene-Editing Therapies CorrectSequence Therapeutics Co., Ltd. is at the forefront of biotechnology innovation with its promising gene-editing therapy, CS-121, designed to tackle chylomicronemia and hypertriglyceridemia. This breakthrough comes as an exciting advancement in the medical field, particularly for patients suffering from severe lipid...

Continue Reading
Blue Ridge Partners Showcases Expertise at PEI Forum Europe

Updated Category News Views 211

Blue Ridge Partners Takes Center Stage at Key Forum Blue Ridge Partners, a leading global management consultancy, will serve as the Knowledge Partner for a significant upcoming event in the private equity sector. The firm is excited to announce its role in the 2025 PEI Operating Partners Forum Europe, taking place in May. Over a decade of collaboration as the Knowledge...

Continue Reading
Alger Russell Innovation Index Q4 2025 Rebalancing Insights

Updated Category News Views 81

Alger Russell Innovation Index Changes for Q4 2025 Fred Alger Management, LLC, a notable growth equity investment manager, has announced significant updates to the Alger Russell Innovation Index. This announcement concerns the quarterly rebalancing that will take place after the trading session concludes. These changes reflect the ever-evolving landscape of investment...

Continue Reading
Partners Value Split Corp. Announces Redemption of Shares

Updated Category News Views 205

Partners Value Split Corp. to Redeem Class AA Preferred Shares Recently, Partners Value Split Corp. (the “Company”) shared exciting news regarding its Class AA Preferred Shares, Series 9. This announcement indicates the Company’s intention to redeem all of its outstanding 5,996,800 Preferred Shares, Series 9 for cash, in accordance with the established terms....

Continue Reading
Pagos' MCP Server: The Future of Payment Data Access?

Updated Category News Views 160

Pagos unveiled a significant upgrade to its Model Context Protocol (MCP) Server on February 17, 2026. This expansion aims to revolutionize how merchants access and analyze their verified payments data directly via AI chat agents like ChatGPT and Claude. Traders in the fintech space are already sizing up this move, pondering whether it marks a genuine leap forward or just...

Continue Reading